Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Journal of Oncology|August 27, 2011
A Cohort Study of p53 Mutations and Protein Accumulation in Benign Breast Tissue and Subsequent Breast Cancer RiskGeoffrey C Kabat, Rita A Kandel, Andrew G Glass, et al.Molecular Endocrinology (Baltimore, Md.)|May 3, 2008
Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cellsSilke Kaulfuss, Michal Grzmil, Bernhard Hemmerlein, et al.Cancer|November 2, 2002
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative womenPhilip E Castle, Sholom Wacholder, Mark E Sherman, et al.Journal of the National Cancer Institute|July 21, 2005
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practiceMichelle J Khan, Philip E Castle, Attila T Lorincz, et al.Sexually Transmitted Diseases|March 5, 2002
Sexual behavior, human papillomavirus type 16 (HPV 16) infection, and HPV 16 seropositivityPhilip E Castle, Tammy Shields, Reinhard Kirnbauer, et al.Journal of the National Cancer Institute|September 19, 2002
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected womenPhilip E Castle, Sholom Wacholder, Attila T Lorincz, et al.Journal of the National Cancer Institute|January 2, 2003
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysisMark E Sherman, Attila T Lorincz, David R Scott, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2005
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancerPhilip E Castle, Mark Schiffman, David R Scott, et al.Mutation Research|June 23, 2007
Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry studyM Margaret Pratt, Paul Sirajuddin, Miriam C Poirier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-upPhilip E Castle, Andrew G Glass, Brenda B Rush, et al.Pageof 6